PT1267931E - Derivados de rodamina para o diagnostico e tratamento fotodinamicos - Google Patents

Derivados de rodamina para o diagnostico e tratamento fotodinamicos

Info

Publication number
PT1267931E
PT1267931E PT00965683T PT00965683T PT1267931E PT 1267931 E PT1267931 E PT 1267931E PT 00965683 T PT00965683 T PT 00965683T PT 00965683 T PT00965683 T PT 00965683T PT 1267931 E PT1267931 E PT 1267931E
Authority
PT
Portugal
Prior art keywords
derivatives
treatment
photodynamic diagnosis
rodamine
rodamine derivatives
Prior art date
Application number
PT00965683T
Other languages
English (en)
Inventor
Roy Denis-Claude
Guimond Martin
Nestor A Molfino
Original Assignee
Hopital Maisonneuve Rosemont
Univ Montreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hopital Maisonneuve Rosemont, Univ Montreal filed Critical Hopital Maisonneuve Rosemont
Publication of PT1267931E publication Critical patent/PT1267931E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0023—Agression treatment or altering
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Transplantation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PT00965683T 1999-10-05 2000-10-03 Derivados de rodamina para o diagnostico e tratamento fotodinamicos PT1267931E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15779099P 1999-10-05 1999-10-05

Publications (1)

Publication Number Publication Date
PT1267931E true PT1267931E (pt) 2005-05-31

Family

ID=22565296

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00965683T PT1267931E (pt) 1999-10-05 2000-10-03 Derivados de rodamina para o diagnostico e tratamento fotodinamicos

Country Status (12)

Country Link
EP (1) EP1267931B1 (pt)
JP (3) JP4859319B2 (pt)
KR (1) KR100697400B1 (pt)
AT (1) ATE285793T1 (pt)
AU (1) AU781855B2 (pt)
BR (1) BR0014135A (pt)
CA (2) CA2699662A1 (pt)
DE (1) DE60017201T2 (pt)
ES (1) ES2234668T3 (pt)
MX (1) MXPA02003522A (pt)
PT (1) PT1267931E (pt)
WO (1) WO2001024824A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8409564B2 (en) 1999-10-05 2013-04-02 Universite De Montreal Rhodamine derivatives for photodynamic diagnosis and treatment
CA2342675A1 (en) 2001-04-02 2002-10-02 Abdelkrim Habi Halogenated rhodamine derivatives and applications thereof
MXPA02011638A (es) * 2001-04-02 2003-05-14 Celmed Biosciences Inc Derivados de rodamina halogenados y aplicaciones de los mismos.
CN1310652C (zh) * 2001-11-29 2007-04-18 特拉科斯有限公司 用体外光提取法和/或凋亡细胞对被试者进行预治疗的方法
MXPA06006286A (es) * 2003-12-05 2006-09-04 Univ Montreal Compuestos inmunologicos para prevencion, proteccion, profilaxis o tratamiento de trastornos inmunologicos, infecciones y cancer.
GB0912584D0 (en) * 2009-07-20 2009-08-26 Ucl Business Plc Cyclosporin conjugates
EP3058957A1 (en) 2015-02-19 2016-08-24 Kiadis Pharma Intellectual Property BV Improved photodynamic process and product obtained therefrom
RU2637279C2 (ru) * 2015-12-25 2017-12-01 Сергей Петрович Кречетов Способ фотодинамической терапии
TWI715927B (zh) * 2019-02-01 2021-01-11 國立清華大學 組合物用於製備治療癌細胞的藥物的用途
EP3730627A1 (en) 2019-04-25 2020-10-28 Kiadis Pharma Intellectual Property BV Method for donor identity verification
EP3769770A1 (en) 2019-07-23 2021-01-27 Kiadis Pharma Intellectual Property BV Method for inhibiting or preventing infection in a transplant recipient
CN115960090B (zh) * 2022-12-30 2024-03-29 中山大学 一种罗丹明b修饰吡啶配体的制备方法及其光催化抗菌应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4321919A (en) * 1979-12-11 1982-03-30 Leukocyte Research, Inc. Method and system for externally treating human blood
AU650998B2 (en) * 1991-06-21 1994-07-07 Baxter International Inc. Method for inactivating pathogens in a body fluid
US5807881A (en) * 1992-05-27 1998-09-15 Quadra Logic Technologies, Inc. Method for selectively reducing activated leukocyte cell population
US5556992A (en) * 1994-09-02 1996-09-17 Universite De Montreal Novel rhodamine derivatives for photodynamic therapy of cancer and in vitro purging of the leukemias
WO1997036581A1 (en) * 1996-03-29 1997-10-09 Therakos, Inc. Photopheresis treatment of leukocytes
CA2270558C (en) * 1996-11-06 2006-08-15 Meiji Seika Kaisha, Ltd. Treatment of autoimmune diseases by photochemotherapy
CA2296366A1 (en) * 1997-07-21 1999-01-28 Cerus Corporation Method of treating leukocytes, leukocyte compositions and methods of use thereof
US20020173523A1 (en) * 1997-08-05 2002-11-21 Yukari Kuroiwa Immunosuppression by photochemotherapy
AU753975B2 (en) * 1997-12-04 2002-10-31 Duke University Methods of isolating and using CD7+CD34-Lin-hematopoietic cells

Also Published As

Publication number Publication date
AU781855B2 (en) 2005-06-16
BR0014135A (pt) 2002-05-21
WO2001024824A1 (en) 2001-04-12
JP2003510372A (ja) 2003-03-18
ES2234668T3 (es) 2005-07-01
AU7635700A (en) 2001-05-10
CA2382885A1 (en) 2001-04-12
CA2382885C (en) 2010-06-29
EP1267931B1 (en) 2004-12-29
EP1267931A1 (en) 2003-01-02
KR100697400B1 (ko) 2007-03-20
JP2011093939A (ja) 2011-05-12
JP4859319B2 (ja) 2012-01-25
ATE285793T1 (de) 2005-01-15
JP5476342B2 (ja) 2014-04-23
DE60017201T2 (de) 2005-12-29
KR20020050234A (ko) 2002-06-26
JP2011229537A (ja) 2011-11-17
CA2699662A1 (en) 2001-04-12
MXPA02003522A (es) 2004-09-10
DE60017201D1 (de) 2005-02-03

Similar Documents

Publication Publication Date Title
HUP0000576A2 (hu) A zöld porfirinek alkalmazása szekunder szürkehályogok kezelésére alkalmas gyógyszerek készítésében
CA2134479A1 (en) Laser treatment
PT1267931E (pt) Derivados de rodamina para o diagnostico e tratamento fotodinamicos
AU2713500A (en) Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
BR9508779A (pt) Derivados de rodamina fototivávies uso dos mesmos e processos para terapia fotodinâmica de um paciente e para purga in vitro de medula óssea
ATE378014T1 (de) System zum behandeln von abnormalem gewebe in der menschlichen speiseröhre
NZ529682A (en) Biologically active methylene blue derivatives
TR199801195T2 (xx) Tedavide yararl� kinolin ve kinozilin bile�ikleri.
DK0933995T3 (da) Fremgangsmåde til behandling af endotelskader
PT946507E (pt) Compostos de pirrolilo substituidos para o tratamento da inflamacao
AR020337A1 (es) Tratamiento de tejidos pigmentados con el uso de energia optica
NL300037I1 (nl) Cytotoxische middelen met een specifieke golflengte.
WO2001039835A8 (en) Device and method for laser biomodulation in pdt/surgery
CY1111404T1 (el) Αντιβιοτικες συνθεσεις οι οποιες πeριεχουν παραγωγα μοξιφλοξασινης για θεραπεια του οφθαλμου
CA2182010A1 (en) Photochemical ablation of gastro-intestinal tissue
AR010701A1 (es) Una composicion de tenido por oxidacion de las fibras queratinicas y procedimiento de tenido que utiliza esta composicion
DK0569113T3 (da) Liposomsammensætninger af porfyrinfotosensibilatorer
ATE224714T1 (de) Behandlung von tinnitus mit neuroprotektiven wirkstoffen
GR1000611B (el) Μεθοδος για την παρασκευη οφθαλμικων συνθεσεων κυκλοσπορινης.
ES2192832T3 (es) Uso de compuestos macrolidos para tratar glaucoma.
CA2339384A1 (en) Improved method for targeted topical treatment of disease
WO2001024825A3 (en) Significance of dosimetry in photodynamic therapy of injured arteries
DE60001555T2 (de) Wässrige lösung zum konservieren von gewebe und organen
WO2003032902A3 (en) Tumor targeted photodiagnostic-phototherapeutic agents
PL339073A1 (en) Derivatives of benzoxazine and benzothiazine and their application in therapeutic agents